Clinical Edge Journal Scan

Early gastric cancer: Outcomes of pylorus-preserving vs conventional distal gastrectomy


 

Key clinical point: In patients with early gastric cancer (EGC), pylorus-preserving gastrectomy (PPG) vs conventional distal gastrectomy (CDG) results in the harvest of fewer lymph nodes at stations 5, 6, 9, and 11p but similar survival outcomes.

Major finding: Patients who underwent PPG vs CDG had significantly lower numbers of lymph nodes harvested at stations 5, 6, 9, and 11p (weighted mean difference, −3.09; P < .001) but similar overall survival (hazard ratio [HR] 0.63; P = .852) and recurrence-free survival (HR 0.29; P = .900).

Study details: This was a meta-analysis of 16 studies including 4500 patients with EGC who had undergone PPG or CDG with lymph node dissection.

Disclosures: This study was sponsored by the Peking University People’s Hospital Research and Development Fund. The authors declared no conflicts of interest.

Source: Hou S et al. Pathological and oncological outcomes of pylorus-preserving versus conventional distal gastrectomy in early gastric cancer: A systematic review and meta-analysis. World J Surg Oncol. 2022;20:308 (Sep 24). Doi: 10.1186/s12957-022-02766-0

Recommended Reading

Pancreatic cancer screening appears safe, effective for high-risk patients
MDedge Hematology and Oncology
EUS-guided RF ablation doubles survival for unresectable pancreatic cancer
MDedge Hematology and Oncology
Some young CRC patients are missing out on genetic counseling, testing
MDedge Hematology and Oncology
Paclitaxel + carboplatin + capecitabine regimen shows promise in advanced gastric cancer
MDedge Hematology and Oncology
Robotic-assisted distal gastrectomy: A feasible treatment option for advanced gastric cancer
MDedge Hematology and Oncology
Multimodal treatment of gastric cancer affects outcomes in a stage‐specific manner
MDedge Hematology and Oncology
Gastric cancer: Neoadjuvant treatment status should not guide the extent of lymphadenectomy
MDedge Hematology and Oncology
Early gastric cancer: Bleeding risk after ESD similar between patients with surgically altered and whole stomach
MDedge Hematology and Oncology
Laparoscopic gastrectomy for gastric cancer: Postoperative NSAID use requires caution
MDedge Hematology and Oncology
Risk factors for delayed gastric emptying following gastrectomy for gastric cancer
MDedge Hematology and Oncology